Nicholas Jason Singer is Director at Eterna Therapeutics Inc. (ERNA). They have made 1 open-market trade across 1 company since 2022, most recently 2022-12-02.
CIK 0001828224
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.9M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ERNA | BUY | 2022-12-02 | 2022-12-06 | $3.28 | $1.9M | -22.8% | -31.2% | -24.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.